| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin binding | ABI3BP BCL7B RUSC1 FHOD3 CLASP2 FMNL2 XIRP2 MICAL2 MACF1 TLN2 CTNNA1 CTNNA2 DMD PHACTR1 | 1.18e-04 | 479 | 180 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | dystroglycan binding | 1.49e-04 | 12 | 180 | 3 | GO:0002162 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.25e-04 | 227 | 180 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | KALRN OBSCN ALS2 ARHGEF11 PLEKHG4B EEF1B2 EEF1D ARHGEF40 DENND2C | 2.56e-04 | 231 | 180 | 9 | GO:0005085 |
| GeneOntologyMolecularFunction | metallopeptidase activity | 4.73e-04 | 200 | 180 | 8 | GO:0008237 | |
| GeneOntologyMolecularFunction | growth hormone-releasing hormone receptor activity | 4.79e-04 | 4 | 180 | 2 | GO:0016520 | |
| GeneOntologyBiologicalProcess | specification of loop of Henle identity | 2.39e-06 | 4 | 175 | 3 | GO:0072086 | |
| GeneOntologyBiologicalProcess | specification of nephron tubule identity | 5.93e-06 | 5 | 175 | 3 | GO:0072081 | |
| GeneOntologyBiologicalProcess | proximal/distal pattern formation involved in nephron development | 5.93e-06 | 5 | 175 | 3 | GO:0072047 | |
| GeneOntologyBiologicalProcess | pattern specification involved in kidney development | 3.26e-05 | 8 | 175 | 3 | GO:0061004 | |
| GeneOntologyBiologicalProcess | renal system pattern specification | 3.26e-05 | 8 | 175 | 3 | GO:0072048 | |
| GeneOntologyBiologicalProcess | extracellular matrix disassembly | 4.25e-05 | 75 | 175 | 6 | GO:0022617 | |
| GeneOntologyBiologicalProcess | loop of Henle development | 6.90e-05 | 10 | 175 | 3 | GO:0072070 | |
| GeneOntologyBiologicalProcess | proximal/distal pattern formation involved in metanephric nephron development | 7.16e-05 | 2 | 175 | 2 | GO:0072272 | |
| GeneOntologyBiologicalProcess | cell junction organization | SORBS2 ABI3BP CLASP1 KALRN ZMYND8 ALS2 CLASP2 IRX3 GHSR IL1RAPL1 SHANK2 CSK XIRP2 MACF1 ERC2 TLN2 C3 CTNNA1 CTNNA2 FLRT1 FYN | 8.26e-05 | 974 | 175 | 21 | GO:0034330 |
| GeneOntologyBiologicalProcess | collagen catabolic process | 8.57e-05 | 53 | 175 | 5 | GO:0030574 | |
| Domain | IRO | 1.03e-07 | 6 | 172 | 4 | SM00548 | |
| Domain | Iroquois_homeo | 1.03e-07 | 6 | 172 | 4 | IPR003893 | |
| Domain | Pept_M10A_Zn_BS | 1.74e-07 | 15 | 172 | 5 | IPR021158 | |
| Domain | PG_binding_1 | 8.66e-07 | 20 | 172 | 5 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 8.66e-07 | 20 | 172 | 5 | IPR002477 | |
| Domain | M10A_MMP | 1.84e-06 | 23 | 172 | 5 | IPR033739 | |
| Domain | Pept_M10A | 1.84e-06 | 23 | 172 | 5 | IPR021190 | |
| Domain | Peptidase_M10 | 2.30e-06 | 24 | 172 | 5 | PF00413 | |
| Domain | Peptidase_Metallo | 6.20e-06 | 29 | 172 | 5 | IPR006026 | |
| Domain | ZnMc | 6.20e-06 | 29 | 172 | 5 | SM00235 | |
| Domain | Homeobox_KN | 1.51e-05 | 17 | 172 | 4 | PF05920 | |
| Domain | Hemopexin_CS | 1.51e-05 | 17 | 172 | 4 | IPR018486 | |
| Domain | Homeobox_KN_domain | 1.51e-05 | 17 | 172 | 4 | IPR008422 | |
| Domain | Pept_M10A_stromelysin-type | 1.92e-05 | 18 | 172 | 4 | IPR016293 | |
| Domain | DH_1 | 2.46e-05 | 63 | 172 | 6 | PS00741 | |
| Domain | Vinculin/catenin | 2.61e-05 | 7 | 172 | 3 | IPR006077 | |
| Domain | CYSTEINE_SWITCH | 3.58e-05 | 41 | 172 | 5 | PS00546 | |
| Domain | RhoGEF | 4.50e-05 | 70 | 172 | 6 | PF00621 | |
| Domain | DH_2 | 4.50e-05 | 70 | 172 | 6 | PS50010 | |
| Domain | Pept_M10_metallopeptidase | 4.53e-05 | 43 | 172 | 5 | IPR001818 | |
| Domain | - | 4.88e-05 | 71 | 172 | 6 | 1.20.900.10 | |
| Domain | DH-domain | 4.88e-05 | 71 | 172 | 6 | IPR000219 | |
| Domain | Hemopexin-like_dom | 5.36e-05 | 23 | 172 | 4 | IPR000585 | |
| Domain | Hemopexin-like_repeat | 5.36e-05 | 23 | 172 | 4 | IPR018487 | |
| Domain | HEMOPEXIN | 5.36e-05 | 23 | 172 | 4 | PS00024 | |
| Domain | - | 5.36e-05 | 23 | 172 | 4 | 2.110.10.10 | |
| Domain | HEMOPEXIN_2 | 5.36e-05 | 23 | 172 | 4 | PS51642 | |
| Domain | HX | 5.36e-05 | 23 | 172 | 4 | SM00120 | |
| Domain | Hemopexin | 5.36e-05 | 23 | 172 | 4 | PF00045 | |
| Domain | EF-1_beta_acid_region_euk | 8.43e-05 | 2 | 172 | 2 | IPR018940 | |
| Domain | EF1_GNE | 8.43e-05 | 2 | 172 | 2 | PF00736 | |
| Domain | Transl_elong_EF1B_B/D_CS | 8.43e-05 | 2 | 172 | 2 | IPR001326 | |
| Domain | EF1_GNE | 8.43e-05 | 2 | 172 | 2 | SM00888 | |
| Domain | EF1BD_1 | 8.43e-05 | 2 | 172 | 2 | PS00824 | |
| Domain | EF1BD_2 | 8.43e-05 | 2 | 172 | 2 | PS00825 | |
| Domain | EF-1_beta_acid | 8.43e-05 | 2 | 172 | 2 | PF10587 | |
| Domain | EF-1_beta_acid | 8.43e-05 | 2 | 172 | 2 | SM01182 | |
| Domain | EF1B_bsu/dsu_GNE | 8.43e-05 | 2 | 172 | 2 | IPR014038 | |
| Domain | SH3 | 1.81e-04 | 216 | 172 | 9 | PS50002 | |
| Domain | SH3_domain | 2.07e-04 | 220 | 172 | 9 | IPR001452 | |
| Domain | Transl_elong_EF1B/ribosomal_S6 | 2.51e-04 | 3 | 172 | 2 | IPR014717 | |
| Domain | - | 2.51e-04 | 3 | 172 | 2 | 3.30.70.60 | |
| Domain | ZINC_PROTEASE | 2.92e-04 | 98 | 172 | 6 | PS00142 | |
| Domain | Myc_N | 5.00e-04 | 4 | 172 | 2 | PF01056 | |
| Domain | CLASP_N | 5.00e-04 | 4 | 172 | 2 | PF12348 | |
| Domain | CLASP_N_dom | 5.00e-04 | 4 | 172 | 2 | IPR024395 | |
| Domain | Alpha_catenin | 5.00e-04 | 4 | 172 | 2 | IPR001033 | |
| Domain | VINCULIN_1 | 5.00e-04 | 4 | 172 | 2 | PS00663 | |
| Domain | Tscrpt_reg_Myc_N | 5.00e-04 | 4 | 172 | 2 | IPR012682 | |
| Domain | Tscrpt_reg_Myc | 5.00e-04 | 4 | 172 | 2 | IPR002418 | |
| Domain | SPHK1-interactor_AKAP_110 | 5.00e-04 | 4 | 172 | 2 | IPR008382 | |
| Domain | Vinculin_CS | 5.00e-04 | 4 | 172 | 2 | IPR000633 | |
| Domain | AKAP_110 | 5.00e-04 | 4 | 172 | 2 | PF05716 | |
| Domain | Vinculin | 8.28e-04 | 5 | 172 | 2 | PF01044 | |
| Domain | WD40 | 8.68e-04 | 268 | 172 | 9 | SM00320 | |
| Domain | SH3 | 8.96e-04 | 216 | 172 | 8 | SM00326 | |
| Domain | - | 9.10e-04 | 81 | 172 | 5 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 9.10e-04 | 81 | 172 | 5 | IPR024079 | |
| Domain | WD40_repeat | 9.63e-04 | 272 | 172 | 9 | IPR001680 | |
| Domain | - | 1.06e-03 | 333 | 172 | 10 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.11e-03 | 335 | 172 | 10 | IPR015943 | |
| Domain | PH | CDC42BPG KALRN OBSCN ALS2 ARHGEF11 GAB2 PLEKHG4B ARHGEF40 RASAL1 | 1.12e-03 | 278 | 172 | 9 | SM00233 |
| Domain | WD_REPEATS_1 | 1.12e-03 | 278 | 172 | 9 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.15e-03 | 279 | 172 | 9 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.15e-03 | 279 | 172 | 9 | PS50294 | |
| Domain | PH_DOMAIN | CDC42BPG KALRN OBSCN ALS2 ARHGEF11 GAB2 PLEKHG4B ARHGEF40 RASAL1 | 1.15e-03 | 279 | 172 | 9 | PS50003 |
| Domain | PH_domain | CDC42BPG KALRN OBSCN ALS2 ARHGEF11 GAB2 PLEKHG4B ARHGEF40 RASAL1 | 1.18e-03 | 280 | 172 | 9 | IPR001849 |
| Domain | Spectrin | 1.19e-03 | 23 | 172 | 3 | PF00435 | |
| Domain | EF-hand_dom_typ1 | 1.23e-03 | 6 | 172 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 1.23e-03 | 6 | 172 | 2 | IPR015154 | |
| Domain | EF-hand_2 | 1.23e-03 | 6 | 172 | 2 | PF09068 | |
| Domain | EF-hand_3 | 1.23e-03 | 6 | 172 | 2 | PF09069 | |
| Domain | PWWP | 1.35e-03 | 24 | 172 | 3 | PS50812 | |
| Domain | WD40_repeat_dom | 1.77e-03 | 297 | 172 | 9 | IPR017986 | |
| Domain | DAD_dom | 2.28e-03 | 8 | 172 | 2 | IPR014767 | |
| Domain | DAD | 2.28e-03 | 8 | 172 | 2 | PS51231 | |
| Domain | Spectrin_repeat | 2.35e-03 | 29 | 172 | 3 | IPR002017 | |
| Domain | Protein_kinase_ATP_BS | 2.75e-03 | 379 | 172 | 10 | IPR017441 | |
| Domain | WD40 | 2.81e-03 | 259 | 172 | 8 | PF00400 | |
| Domain | SPEC | 3.13e-03 | 32 | 172 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.13e-03 | 32 | 172 | 3 | IPR018159 | |
| Domain | - | CDC42BPG KALRN OBSCN ALS2 ARHGEF11 GAB2 PLEKHG4B ARHGEF40 TLN2 RASAL1 | 3.44e-03 | 391 | 172 | 10 | 2.30.29.30 |
| Domain | RhoGEF | 3.58e-03 | 68 | 172 | 4 | SM00325 | |
| Domain | fn3 | 3.92e-03 | 162 | 172 | 6 | PF00041 | |
| Domain | ARM-type_fold | 4.26e-03 | 339 | 172 | 9 | IPR016024 | |
| Domain | GBD/FH3_dom | 4.39e-03 | 11 | 172 | 2 | IPR014768 | |
| Domain | GBD_FH3 | 4.39e-03 | 11 | 172 | 2 | PS51232 | |
| Domain | Kinase-like_dom | CDC42BPG KALRN OBSCN ARAF NEK1 NEK3 CSK NRK MACF1 DMD FYN DYRK3 | 4.49e-03 | 542 | 172 | 12 | IPR011009 |
| Domain | GDS_CDC24_CS | 5.50e-03 | 39 | 172 | 3 | IPR001331 | |
| Domain | PH_dom-like | CDC42BPG KALRN OBSCN ALS2 ARHGEF11 GAB2 PLEKHG4B ARHGEF40 TLN2 RASAL1 | 6.22e-03 | 426 | 172 | 10 | IPR011993 |
| Domain | Dynein_heavy_chain_D4_dom | 7.13e-03 | 14 | 172 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 7.13e-03 | 14 | 172 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 7.13e-03 | 14 | 172 | 2 | IPR013602 | |
| Domain | DHC_N2 | 7.13e-03 | 14 | 172 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 7.13e-03 | 14 | 172 | 2 | IPR011704 | |
| Domain | MT | 7.13e-03 | 14 | 172 | 2 | PF12777 | |
| Domain | AAA_8 | 7.13e-03 | 14 | 172 | 2 | PF12780 | |
| Domain | CNH | 7.13e-03 | 14 | 172 | 2 | SM00036 | |
| Domain | AAA_5 | 7.13e-03 | 14 | 172 | 2 | PF07728 | |
| Domain | FN3 | 7.41e-03 | 185 | 172 | 6 | SM00060 | |
| Pathway | WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION | 1.91e-07 | 46 | 130 | 7 | M46450 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | 6.14e-06 | 29 | 130 | 5 | MM15981 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | 7.31e-06 | 30 | 130 | 5 | M39652 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 3.55e-05 | 41 | 130 | 5 | MM15200 | |
| Pathway | BIOCARTA_CELL2CELL_PATHWAY | 6.18e-05 | 9 | 130 | 3 | MM1366 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 8.50e-05 | 49 | 130 | 5 | MM14837 | |
| Pathway | BIOCARTA_CELL2CELL_PATHWAY | 1.59e-04 | 12 | 130 | 3 | M12851 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 2.03e-04 | 32 | 130 | 4 | M29579 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 2.30e-04 | 33 | 130 | 4 | M27016 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 2.58e-04 | 34 | 130 | 4 | M27041 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.90e-04 | 35 | 130 | 4 | M27320 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 3.24e-04 | 36 | 130 | 4 | M26974 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 3.24e-04 | 36 | 130 | 4 | M27245 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 3.27e-04 | 65 | 130 | 5 | MM15147 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 3.60e-04 | 37 | 130 | 4 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 3.60e-04 | 37 | 130 | 4 | M27038 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 4.42e-04 | 39 | 130 | 4 | M27238 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 4.88e-04 | 40 | 130 | 4 | MM14945 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 4.94e-04 | 71 | 130 | 5 | M27394 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 5.37e-04 | 41 | 130 | 4 | M29574 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 5.89e-04 | 42 | 130 | 4 | MM15039 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 5.98e-04 | 74 | 130 | 5 | M48006 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 6.45e-04 | 43 | 130 | 4 | MM14609 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 6.45e-04 | 43 | 130 | 4 | M26975 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 7.04e-04 | 44 | 130 | 4 | M109 | |
| Pathway | REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION | 8.29e-04 | 5 | 130 | 2 | MM14603 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 8.35e-04 | 46 | 130 | 4 | M27397 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 9.06e-04 | 47 | 130 | 4 | M27395 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 9.06e-04 | 47 | 130 | 4 | MM14939 | |
| Pathway | PID_AJDISS_2PATHWAY | 9.82e-04 | 48 | 130 | 4 | M142 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.15e-03 | 50 | 130 | 4 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.23e-03 | 51 | 130 | 4 | MM15151 | |
| Pubmed | 2.11e-10 | 8 | 183 | 5 | 11118473 | ||
| Pubmed | DLGAP1 CAD SORBS2 CLASP1 KALRN HECTD4 DIDO1 CLASP2 ARHGEF11 AKAP12 SEPTIN3 SHANK2 SYNJ1 SPHKAP ZBTB21 MIOS MACF1 ERC2 TLN2 CTNNA1 CTNNA2 TAF5 RASAL1 PHACTR1 | 3.18e-10 | 963 | 183 | 24 | 28671696 | |
| Pubmed | 1.72e-09 | 11 | 183 | 5 | 10926765 | ||
| Pubmed | Iroquois genes influence proximo-distal morphogenesis during rat lung development. | 3.69e-09 | 5 | 183 | 4 | 16299054 | |
| Pubmed | Expression of two novel mouse Iroquois homeobox genes during neurogenesis. | 3.69e-09 | 5 | 183 | 4 | 10704856 | |
| Pubmed | Comparison of Iroquois gene expression in limbs/fins of vertebrate embryos. | 1.10e-08 | 6 | 183 | 4 | 20408909 | |
| Pubmed | 1.10e-08 | 6 | 183 | 4 | 11042145 | ||
| Pubmed | 1.10e-08 | 6 | 183 | 4 | 36773339 | ||
| Pubmed | Regulated expression patterns of IRX-2, an Iroquois-class homeobox gene, in the human breast. | 1.10e-08 | 6 | 183 | 4 | 10370142 | |
| Pubmed | 1.59e-08 | 16 | 183 | 5 | 20484597 | ||
| Pubmed | Fine physical mapping of the human matrix metalloproteinase genes clustered on chromosome 11q22.3. | 2.56e-08 | 7 | 183 | 4 | 8921407 | |
| Pubmed | The prepattern transcription factor Irx3 directs nephron segment identity. | 2.56e-08 | 7 | 183 | 4 | 17875669 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DLGAP1 SORBS2 KALRN SHANK2 SYNJ1 SACS MACF1 TLN2 AKAP11 CTNNA2 RASAL1 PHACTR1 | 3.66e-08 | 281 | 183 | 12 | 28706196 |
| Pubmed | 5.11e-08 | 8 | 183 | 4 | 10822268 | ||
| Pubmed | 9.16e-08 | 9 | 183 | 4 | 14585979 | ||
| Pubmed | Gene and cluster-specific expression of the Iroquois family members during mouse development. | 9.16e-08 | 9 | 183 | 4 | 11520674 | |
| Pubmed | Functional interactions between matrix metalloproteinases and glycosaminoglycans. | 9.35e-08 | 22 | 183 | 5 | 23421805 | |
| Pubmed | 9.35e-08 | 22 | 183 | 5 | 10419448 | ||
| Pubmed | DLGAP1 SORBS2 KALRN SEPTIN3 SHANK2 SYNJ1 MACF1 ERC2 TLN2 CTNNA2 RASAL1 | 1.06e-07 | 251 | 183 | 11 | 27507650 | |
| Pubmed | 1.43e-07 | 3 | 183 | 3 | 9486539 | ||
| Pubmed | 1.43e-07 | 3 | 183 | 3 | 35328612 | ||
| Pubmed | Cardiomyopathy in Irx4-deficient mice is preceded by abnormal ventricular gene expression. | 2.30e-07 | 26 | 183 | 5 | 11238910 | |
| Pubmed | 5.71e-07 | 4 | 183 | 3 | 23343931 | ||
| Pubmed | 5.71e-07 | 4 | 183 | 3 | 29317790 | ||
| Pubmed | 5.71e-07 | 4 | 183 | 3 | 21410539 | ||
| Pubmed | 5.71e-07 | 4 | 183 | 3 | 9348221 | ||
| Pubmed | Cloning and chromosome mapping of human and chicken Iroquois (IRX) genes. | 5.71e-07 | 4 | 183 | 3 | 11435706 | |
| Pubmed | DLGAP1 CAD SORBS2 CLASP1 KALRN CLASP2 ARHGEF11 FMNL2 EEF1B2 EEF1D SHANK2 SYNJ1 SACS MICAL2 MIOS KCNQ3 MACF1 ERC2 TLN2 CTNNA1 CTNNA2 DMD DNAH6 RASAL1 | 5.72e-07 | 1431 | 183 | 24 | 37142655 | |
| Pubmed | EDF1 CAD KMT2B CLASP1 INTS7 MED16 ZMYND8 DIDO1 CLASP2 ERMP1 ARHGEF11 ARAF RMDN3 EEF1B2 SEPTIN3 SHANK2 WDR20 TNRC6A MIOS MACF1 CTNNA2 SUZ12 TAF5 ASCC3 | 1.26e-06 | 1497 | 183 | 24 | 31527615 | |
| Pubmed | 1.28e-06 | 16 | 183 | 4 | 10949577 | ||
| Pubmed | 1.28e-06 | 16 | 183 | 4 | 37701782 | ||
| Pubmed | Role of CLASP2 in microtubule stabilization and the regulation of persistent motility. | 1.42e-06 | 5 | 183 | 3 | 17113391 | |
| Pubmed | 1.42e-06 | 5 | 183 | 3 | 18308831 | ||
| Pubmed | 1.42e-06 | 5 | 183 | 3 | 20827277 | ||
| Pubmed | 1.42e-06 | 5 | 183 | 3 | 17373931 | ||
| Pubmed | 1.42e-06 | 5 | 183 | 3 | 24043512 | ||
| Pubmed | 1.42e-06 | 5 | 183 | 3 | 11335133 | ||
| Pubmed | Nitric oxide-mediated invasion in Barrett's high-grade dysplasia and adenocarcinoma. | 1.42e-06 | 5 | 183 | 3 | 20584750 | |
| Pubmed | DLGAP1 ABI3BP NUP98 ARHGEF11 FMNL2 ARAF GAB2 RMDN3 TNRC6A MACF1 CTNNA1 DMD GAREM1 | 2.06e-06 | 486 | 183 | 13 | 20936779 | |
| Pubmed | Wnt/β-catenin promotes gastric fundus specification in mice and humans. | 2.14e-06 | 18 | 183 | 4 | 28052057 | |
| Pubmed | Expression analysis of the entire MMP and TIMP gene families during mouse tissue development. | 2.70e-06 | 19 | 183 | 4 | 15063736 | |
| Pubmed | DLGAP1 CAD SORBS2 KALRN ETFA ZDBF2 EEF1B2 EEF1D SEPTIN3 SHANK2 SYNJ1 SPHKAP TNRC6A KCNQ3 MACF1 TLN2 CTNNA2 LNPK RASAL1 PHACTR1 | 2.72e-06 | 1139 | 183 | 20 | 36417873 | |
| Pubmed | Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. | 2.83e-06 | 6 | 183 | 3 | 7694569 | |
| Pubmed | 2.83e-06 | 6 | 183 | 3 | 18006768 | ||
| Pubmed | Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population. | 2.83e-06 | 6 | 183 | 3 | 19132754 | |
| Pubmed | Tissue inhibitor of metalloproteinase 1 regulates resistance to infection. | 2.83e-06 | 6 | 183 | 3 | 15618213 | |
| Pubmed | 2.83e-06 | 6 | 183 | 3 | 19643940 | ||
| Pubmed | 4.94e-06 | 7 | 183 | 3 | 11113146 | ||
| Pubmed | 4.94e-06 | 7 | 183 | 3 | 17607721 | ||
| Pubmed | 6.84e-06 | 246 | 183 | 9 | 15345747 | ||
| Pubmed | 7.26e-06 | 24 | 183 | 4 | 15734845 | ||
| Pubmed | Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites. | 1.18e-05 | 9 | 183 | 3 | 10986281 | |
| Pubmed | 1.62e-05 | 209 | 183 | 8 | 36779422 | ||
| Pubmed | 1.67e-05 | 10 | 183 | 3 | 23001180 | ||
| Pubmed | Mapping of multiple mouse loci related to the farnesyl pyrophosphate synthetase gene. | 1.67e-05 | 10 | 183 | 3 | 8499655 | |
| Pubmed | ACF7 regulates cytoskeletal-focal adhesion dynamics and migration and has ATPase activity. | 1.67e-05 | 10 | 183 | 3 | 18854161 | |
| Pubmed | 1.73e-05 | 102 | 183 | 6 | 11214970 | ||
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | 1.86e-05 | 351 | 183 | 10 | 20453000 | |
| Pubmed | 1.97e-05 | 281 | 183 | 9 | 24163370 | ||
| Pubmed | USP22 BCL7B ZMYND8 DCAF16 FMNL2 ARAF RMDN3 FAT1 ARHGEF40 WDR20 ZBTB21 TNRC6A MACF1 NUP188 SUZ12 TAF5 ASCC3 IRX2 | 2.72e-05 | 1116 | 183 | 18 | 31753913 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 16914514 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 18031309 | ||
| Pubmed | The collagenase gene family in humans consists of at least four members. | 2.75e-05 | 2 | 183 | 2 | 2844164 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 32662900 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 36231910 | ||
| Pubmed | Mammalian CLASPs are required for mitotic spindle organization and kinetochore alignment. | 2.75e-05 | 2 | 183 | 2 | 16866869 | |
| Pubmed | Application of MMP-7 and MMP-10 in assisting the diagnosis of malignant pleural effusion. | 2.75e-05 | 2 | 183 | 2 | 22524815 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 17998934 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 22499340 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 8262983 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 17672933 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 19701196 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 2605216 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 26445891 | ||
| Pubmed | The role of DNA hypomethylation in the control of stromelysin gene expression. | 2.75e-05 | 2 | 183 | 2 | 16516860 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 24146820 | ||
| Pubmed | Loss of the matrix metalloproteinase-10 causes premature features of aging in satellite cells. | 2.75e-05 | 2 | 183 | 2 | 37228645 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 33404658 | ||
| Pubmed | Genetic variation in the matrix metalloproteinase genes and diabetic nephropathy in type 1 diabetes. | 2.75e-05 | 2 | 183 | 2 | 21277817 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 24123596 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 1985196 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 30246301 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 17923522 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 10642592 | ||
| Pubmed | A genome-wide association study reveals 2 new susceptibility loci for atopic dermatitis. | 2.75e-05 | 2 | 183 | 2 | 25865352 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 27987113 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 18253029 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 20736794 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 19690958 | ||
| Pubmed | The human L-myc gene encodes multiple nuclear phosphoproteins from alternatively processed mRNAs. | 2.75e-05 | 2 | 183 | 2 | 3054516 | |
| Pubmed | Human CLASP1 is an outer kinetochore component that regulates spindle microtubule dynamics. | 2.75e-05 | 2 | 183 | 2 | 12837247 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 27453922 | ||
| Pubmed | Monomeric α-catenin links cadherin to the actin cytoskeleton. | 2.75e-05 | 2 | 183 | 2 | 23417122 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 35502585 | ||
| Pubmed | Impaired development of CD4+ CD8+ thymoyctes by csk-'knock-in' into fyn locus. | 2.75e-05 | 2 | 183 | 2 | 8700547 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 2827002 | ||
| Pubmed | Extensive pleiotropism and allelic heterogeneity mediate metabolic effects of IRX3 and IRX5. | 2.75e-05 | 2 | 183 | 2 | 34083488 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 32108023 | ||
| Pubmed | Apparent tradeoff of higher activity in MMP-12 for enhanced stability and flexibility in MMP-3. | 2.75e-05 | 2 | 183 | 2 | 20655856 | |
| Pubmed | Mast, a conserved microtubule-associated protein required for bipolar mitotic spindle organization. | 2.75e-05 | 2 | 183 | 2 | 10899121 | |
| Interaction | MMP16 interactions | 1.63e-05 | 18 | 178 | 4 | int:MMP16 | |
| Interaction | MMP1 interactions | 1.76e-05 | 37 | 178 | 5 | int:MMP1 | |
| Interaction | AGAP2 interactions | DLGAP1 SORBS2 KALRN SHANK2 SYNJ1 SACS MACF1 TLN2 RASAL1 PHACTR1 | 1.81e-05 | 210 | 178 | 10 | int:AGAP2 |
| Interaction | MMP24 interactions | 2.06e-05 | 19 | 178 | 4 | int:MMP24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q22 | 2.76e-07 | 107 | 184 | 7 | chr11q22 | |
| Cytoband | 11q22.3 | 2.99e-05 | 44 | 184 | 4 | 11q22.3 | |
| Cytoband | 2q33.3 | 2.37e-04 | 30 | 184 | 3 | 2q33.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq22 | 6.75e-04 | 172 | 184 | 5 | chrXq22 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 3.84e-07 | 24 | 116 | 5 | 891 | |
| GeneFamily | TALE class homeoboxes and pseudogenes | 2.16e-05 | 26 | 116 | 4 | 526 | |
| GeneFamily | Nucleoporins | 5.04e-05 | 32 | 116 | 4 | 1051 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.52e-05 | 66 | 116 | 5 | 722 | |
| GeneFamily | WD repeat domain containing | 2.88e-04 | 262 | 116 | 8 | 362 | |
| GeneFamily | PWWP domain containing | 3.63e-04 | 22 | 116 | 3 | 1147 | |
| GeneFamily | Fibronectin type III domain containing | 5.82e-04 | 160 | 116 | 6 | 555 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 8.33e-04 | 29 | 116 | 3 | 396 | |
| GeneFamily | Aminopeptidases|CD molecules | 5.21e-03 | 17 | 116 | 2 | 104 | |
| GeneFamily | Beta 4-glycosyltransferases | 5.21e-03 | 17 | 116 | 2 | 425 | |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_UP | MYCL TRGC1 DIDO1 SYCP2 MANSC1 SHANK2 SYNJ1 WDR20 DENND2C MIOS TLN2 RIPOR1 SCPEP1 PWWP3B VPS13B GAREM1 | 2.76e-06 | 583 | 179 | 16 | M17454 |
| Coexpression | GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN | 9.76e-06 | 199 | 179 | 9 | M9393 | |
| Coexpression | GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_DN | B4GALNT1 APCDD1 ATP13A5 GPAM ZNF317 AKAP12 SLC24A4 CSK GALNT6 | 9.76e-06 | 199 | 179 | 9 | M7183 |
| Coexpression | GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP | 1.02e-05 | 200 | 179 | 9 | M6539 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#2 | 8.19e-06 | 122 | 176 | 8 | Facebase_RNAseq_e8.5_Floor Plate_1000_K2 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | SORBS2 IRX5 IRX3 IRX1 PLEKHG4B FREM2 SHANK2 ERC2 SLC38A11 GALNT6 IRX2 | 4.31e-10 | 190 | 183 | 11 | 625c08a0e5227efc46daa512fd579c3938ff76c7 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-09 | 184 | 183 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-09 | 184 | 183 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-09 | 184 | 183 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.17e-09 | 188 | 183 | 10 | 3cfba3addcc9058f4ec31ad96261f79988f551a0 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | SORBS2 ZMYND8 OBSCN FHOD3 IL1RAPL1 XIRP2 SPHKAP TLN2 PHACTR1 | 6.44e-08 | 181 | 183 | 9 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.41e-08 | 184 | 183 | 9 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.77e-08 | 185 | 183 | 9 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.13e-08 | 186 | 183 | 9 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.52e-08 | 187 | 183 | 9 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | SORBS2 OBSCN FHOD3 IL1RAPL1 XIRP2 SPHKAP B4GALNT3 DMD PHACTR1 | 9.33e-08 | 189 | 183 | 9 | 5e80c47f63980904c4c1ff02c201b67b456a0974 |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 9.76e-08 | 190 | 183 | 9 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.02e-07 | 191 | 183 | 9 | 05731ece7867659c662f952812805f947032fe10 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.02e-07 | 191 | 183 | 9 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.07e-07 | 192 | 183 | 9 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.33e-07 | 197 | 183 | 9 | ad6f047d003c08413264f39a30ba0f7639a257cd | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.39e-07 | 198 | 183 | 9 | d12f37527399038a8f030b45b176bda5c7c8a7ad | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.51e-07 | 200 | 183 | 9 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|RV / Chamber and Cluster_Paper | 2.67e-07 | 105 | 183 | 7 | 49e16b11f16e83a7d17d162c14bce991201bcc2a | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-07 | 158 | 183 | 8 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-07 | 158 | 183 | 8 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.40e-07 | 174 | 183 | 8 | d0e3d15731de6c19c232e3aa492c39d8151cf4ed | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 7.41e-07 | 122 | 183 | 7 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.93e-07 | 179 | 183 | 8 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.99e-07 | 182 | 183 | 8 | a95956ce4adccb34cc0c47ebfa1878ce4617904e | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.37e-07 | 183 | 183 | 8 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.37e-07 | 183 | 183 | 8 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 9.76e-07 | 184 | 183 | 8 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-06 | 185 | 183 | 8 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-06 | 185 | 183 | 8 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-06 | 185 | 183 | 8 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-06 | 185 | 183 | 8 | 929b68b05b7686341329ac756d7df172cb4b810b | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-06 | 186 | 183 | 8 | e0a2ea4b46af742bc7c9b2072bb85e27d5c92712 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.10e-06 | 187 | 183 | 8 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.15e-06 | 188 | 183 | 8 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.15e-06 | 188 | 183 | 8 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.15e-06 | 188 | 183 | 8 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.19e-06 | 189 | 183 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.19e-06 | 189 | 183 | 8 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.24e-06 | 190 | 183 | 8 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.24e-06 | 190 | 183 | 8 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.24e-06 | 190 | 183 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.29e-06 | 191 | 183 | 8 | 72dbd2e0fabfca8d6f604df35277d3574739a0b3 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.29e-06 | 191 | 183 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 1.34e-06 | 192 | 183 | 8 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.34e-06 | 192 | 183 | 8 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.40e-06 | 193 | 183 | 8 | aa10924b203c71e65fdbd2b90ba131dbd362d8b1 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.40e-06 | 193 | 183 | 8 | 4b8202fcfe639a73f69a13f48fc3601ade256346 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.45e-06 | 194 | 183 | 8 | c5ef4ff73b4e51530656002e3a2fb7264cdf533d | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.45e-06 | 194 | 183 | 8 | c011cd59bb4ca4134331cba0f5d73bdbd7011d64 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.45e-06 | 194 | 183 | 8 | 7b2b40a56eb9c7203ca50133b2da4fd8fdd4a5cf | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.45e-06 | 194 | 183 | 8 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.51e-06 | 195 | 183 | 8 | f08e41706680881ebd0afcd08a02f8ac0089f04e | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.51e-06 | 195 | 183 | 8 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-06 | 196 | 183 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.57e-06 | 196 | 183 | 8 | 0a34a0009f479384f1994c6f977f942699a132c8 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.63e-06 | 197 | 183 | 8 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.63e-06 | 197 | 183 | 8 | 1638959d7aecb9fc5285eb7e4a3103ca437989e2 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.63e-06 | 197 | 183 | 8 | f870a26f322668781e3d2832c5d9ef2c7c91011f | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.63e-06 | 197 | 183 | 8 | 2f91b3870a7058168093a143110954c07588cfe9 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|Control_saline / Treatment groups by lineage, cell group, cell type | 1.69e-06 | 198 | 183 | 8 | 030ef63e2fc5b3d601c1a48462d797aa19ee7ff5 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.69e-06 | 198 | 183 | 8 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-06 | 198 | 183 | 8 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-06 | 198 | 183 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.69e-06 | 198 | 183 | 8 | 6b6572deeca98ccb015f2aa3c5ce27de44445f74 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.69e-06 | 198 | 183 | 8 | c4e7512f0e1d115f2be8acae6048eda8b6b640b2 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.69e-06 | 198 | 183 | 8 | 9a12e5e47236433e512c668005fe3f8be6fde95c | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.75e-06 | 199 | 183 | 8 | af664e0d41a889a75dbf6cf0d50acd26f5ab3a3a | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.37e-06 | 153 | 183 | 7 | 5501095bcf73080872ae01128f21399f9cfc5dd1 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.52e-06 | 154 | 183 | 7 | 5967a0a33456d5930fc492a700ebb015ac050abb | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.68e-06 | 155 | 183 | 7 | fab281db4c275d51240b122be78713c839ba5a95 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.30e-06 | 103 | 183 | 6 | c11bb0238e81a42dad5d7687c9d22474129d803d | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-06 | 163 | 183 | 7 | cab65dabeea58141c649e4fec5e0123beb3de1b3 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.01e-06 | 167 | 183 | 7 | 25af48c640e67848594f5902867ba325fc105da4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.25e-06 | 168 | 183 | 7 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.75e-06 | 170 | 183 | 7 | 5a64e05c263df915085988d881808221e2c0f2e2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-06 | 171 | 183 | 7 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.29e-06 | 172 | 183 | 7 | eba1568d4307e91c94fc616549057cbed8df5840 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.57e-06 | 173 | 183 | 7 | ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.57e-06 | 173 | 183 | 7 | 3725525b99a6011eda2ff5459b4fd2e1eab1f090 | |
| ToppCell | Substantia_nigra|World / BrainAtlas - Mouse McCarroll V32 | 8.13e-06 | 115 | 183 | 6 | 18174b8d57d444fab1e9d2b13d22939c83c958e0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.16e-06 | 175 | 183 | 7 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | PBMC-Severe-cDC_11|Severe / Compartment, Disease Groups and Clusters | 9.12e-06 | 178 | 183 | 7 | 0667abc05eb2254710b9c648c65b7cfdfe7831b7 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.45e-06 | 179 | 183 | 7 | dfd9d29281510d32f1a2e8336d2e58ef496cfd1d | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.80e-06 | 180 | 183 | 7 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 9.80e-06 | 180 | 183 | 7 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-05 | 181 | 183 | 7 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.02e-05 | 181 | 183 | 7 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-05 | 182 | 183 | 7 | e97681a4102f3095d5d9e90ad70f1dc46e90983a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.09e-05 | 183 | 183 | 7 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-05 | 183 | 183 | 7 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 184 | 183 | 7 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.13e-05 | 184 | 183 | 7 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-05 | 184 | 183 | 7 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.13e-05 | 184 | 183 | 7 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.13e-05 | 184 | 183 | 7 | fa4915b0498f3069fd5ef497286445528f75187e | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.17e-05 | 185 | 183 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-05 | 185 | 183 | 7 | 8ca1374501eca01d8468130b74d50abfd4329fbe | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.17e-05 | 185 | 183 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-05 | 185 | 183 | 7 | 68f428e169cfb77de970bdfdeea9b9f16f68d2ba | |
| Computational | MMPs. | 4.88e-05 | 21 | 107 | 4 | MODULE_562 | |
| Computational | Genes in the cancer module 211. | 1.49e-04 | 11 | 107 | 3 | MODULE_211 | |
| Computational | Genes in the cancer module 210. | 1.58e-04 | 28 | 107 | 4 | MODULE_210 | |
| Computational | Metal / Ca ion binding. | 3.54e-04 | 133 | 107 | 7 | MODULE_324 | |
| Drug | AC1L9M3B | 5.03e-07 | 61 | 179 | 7 | CID000448562 | |
| Drug | DA-125 | 1.63e-06 | 26 | 179 | 5 | CID000114758 | |
| Drug | mercuric acetate | 3.45e-06 | 30 | 179 | 5 | CID000015337 | |
| Drug | novobiocin sodium, USP; Up 200; 100uM; MCF7; HG-U133A | NPPA CLASP1 PRPH2 JAM2 SEMA6D KCNQ3 TLN2 NUP188 FLRT1 TMEM19 | 3.98e-06 | 198 | 179 | 10 | 342_UP |
| Drug | malolactomycin D | 4.81e-06 | 32 | 179 | 5 | CID006449115 | |
| Drug | macrocyclic inhibitor 4 | 5.64e-06 | 33 | 179 | 5 | CID016124959 | |
| Drug | 4-aminophenyl | 9.27e-06 | 62 | 179 | 6 | CID000181201 | |
| Disease | matrix metalloproteinase measurement | 8.58e-07 | 13 | 177 | 4 | EFO_0004744 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 2.73e-05 | 144 | 177 | 7 | EFO_0004611, EFO_0020943 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 3.07e-05 | 60 | 177 | 5 | EFO_0022282 | |
| Disease | arteriosclerosis (is_implicated_in) | 3.47e-05 | 31 | 177 | 4 | DOID:2349 (is_implicated_in) | |
| Disease | Short rib-polydactyly syndrome, Majewski type | 3.58e-05 | 2 | 177 | 2 | cv:CN305384 | |
| Disease | matrix metalloproteinase measurement, Alzheimer disease, Alzheimer's disease biomarker measurement | 3.58e-05 | 2 | 177 | 2 | EFO_0004744, EFO_0006514, MONDO_0004975 | |
| Disease | level of stromelysin-1 in blood serum | 3.58e-05 | 2 | 177 | 2 | OBA_2042390 | |
| Disease | Vasodilators used in cardiac diseases use measurement | 5.04e-05 | 34 | 177 | 4 | EFO_0009926 | |
| Disease | total lipids in large HDL | 8.46e-05 | 74 | 177 | 5 | EFO_0022189 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 8.46e-05 | 74 | 177 | 5 | EFO_0022280 | |
| Disease | dilated cardiomyopathy (is_marker_for) | 8.74e-05 | 39 | 177 | 4 | DOID:12930 (is_marker_for) | |
| Disease | Butterfly-shaped pigmentary macular dystrophy | 1.07e-04 | 3 | 177 | 2 | C4511237 | |
| Disease | Patterned dystrophy of retinal pigment epithelium | 1.07e-04 | 3 | 177 | 2 | C1868569 | |
| Disease | Macular Dystrophy, Butterfly-Shaped Pigmentary, 2 | 1.07e-04 | 3 | 177 | 2 | C1837029 | |
| Disease | cholesterol in large HDL measurement | 1.23e-04 | 80 | 177 | 5 | EFO_0021900 | |
| Disease | matrix metalloproteinase 12 measurement | 1.62e-04 | 18 | 177 | 3 | EFO_0010590 | |
| Disease | PR interval | KALRN CEP85L OBSCN FREM2 FAT1 ARHGEF40 MICAL2 SCN10A MACF1 DLEC1 GAREM1 | 2.13e-04 | 495 | 177 | 11 | EFO_0004462 |
| Disease | free cholesterol to total lipids in small HDL percentage | 2.51e-04 | 51 | 177 | 4 | EFO_0022285 | |
| Disease | Malignant neoplasm of breast | RTP1 KALRN DYNC2H1 CEP85L OBSCN NUP98 ARAF AKAP12 EEF1B2 HEATR9 MACF1 DLEC1 MMP3 DMD MMP10 REPS2 VPS13B | 2.70e-04 | 1074 | 177 | 17 | C0006142 |
| Disease | resting heart rate | 2.89e-04 | 149 | 177 | 6 | EFO_0004351 | |
| Disease | economic and social preference | 3.03e-04 | 97 | 177 | 5 | EFO_0004827 | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 3.36e-04 | 55 | 177 | 4 | EFO_0022288 | |
| Disease | coronary artery disease (is_implicated_in) | 3.49e-04 | 100 | 177 | 5 | DOID:3393 (is_implicated_in) | |
| Disease | sexual dimorphism measurement | GDF5-AS1 DIS3L2 AOC1 KMT2B ETFA GPAM APOB LCAT DCAF16 GHSR ARHGEF40 PCIF1 TNRC6A MACF1 ERC2 B4GALNT3 SUCO | 3.78e-04 | 1106 | 177 | 17 | EFO_0021796 |
| Disease | Intellectual Disability | EEF1B2 SHANK2 MIR17HG SACS MACF1 CTNNA2 SUZ12 LNPK ASCC3 PHACTR1 | 3.91e-04 | 447 | 177 | 10 | C3714756 |
| Disease | Coronary heart disease | 3.91e-04 | 24 | 177 | 3 | C0010068 | |
| Disease | stearoylcarnitine measurement | 3.91e-04 | 24 | 177 | 3 | EFO_0021045 | |
| Disease | triglycerides to total lipids in large HDL percentage | 4.70e-04 | 60 | 177 | 4 | EFO_0022330 | |
| Disease | free cholesterol in HDL measurement | 5.00e-04 | 61 | 177 | 4 | EFO_0022264 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 5.00e-04 | 61 | 177 | 4 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | fractalkine measurement | 5.28e-04 | 6 | 177 | 2 | EFO_0020395 | |
| Disease | v-set and transmembrane domain-containing protein 4 measurement | 5.28e-04 | 6 | 177 | 2 | EFO_0803247 | |
| Disease | VACTERL association (implicated_via_orthology) | 5.28e-04 | 6 | 177 | 2 | DOID:14679 (implicated_via_orthology) | |
| Disease | stromelysin-2 measurement | 5.28e-04 | 6 | 177 | 2 | EFO_0802095 | |
| Disease | Lissencephaly | 5.28e-04 | 6 | 177 | 2 | C0266463 | |
| Disease | total lipids in HDL measurement | 5.66e-04 | 63 | 177 | 4 | EFO_0022307 | |
| Disease | hair color | 6.09e-04 | 311 | 177 | 8 | EFO_0003924 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 7.14e-04 | 67 | 177 | 4 | EFO_0008595, EFO_0020946 | |
| Disease | regulator of G-protein signaling 8 measurement | 7.37e-04 | 7 | 177 | 2 | EFO_0801997 | |
| Disease | asphyxiating thoracic dystrophy (is_implicated_in) | 7.37e-04 | 7 | 177 | 2 | DOID:0050592 (is_implicated_in) | |
| Disease | endoplasmic reticulum aminopeptidase 1 measurement | 7.37e-04 | 7 | 177 | 2 | EFO_0008119 | |
| Disease | crescentic glomerulonephritis (biomarker_via_orthology) | 9.78e-04 | 8 | 177 | 2 | DOID:13139 (biomarker_via_orthology) | |
| Disease | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 measurement | 9.78e-04 | 8 | 177 | 2 | EFO_0801373 | |
| Disease | calcium/calmodulin-dependent protein kinase type 1D measurement | 9.78e-04 | 8 | 177 | 2 | EFO_0008063 | |
| Disease | phospholipids in large HDL measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022190 | |
| Disease | cellular retinoic acid-binding protein 1 measurement | 1.25e-03 | 9 | 177 | 2 | EFO_0801463 | |
| Disease | Lung diseases | 1.26e-03 | 78 | 177 | 4 | C0024115 | |
| Disease | cholesteryl esters to total lipids in very large HDL percentage | 1.31e-03 | 36 | 177 | 3 | EFO_0022257 | |
| Disease | free cholesterol in large HDL measurement | 1.32e-03 | 79 | 177 | 4 | EFO_0022157 | |
| Disease | exploratory eye movement measurement | 1.45e-03 | 81 | 177 | 4 | EFO_0007700 | |
| Disease | renal hypertension (biomarker_via_orthology) | 1.56e-03 | 10 | 177 | 2 | DOID:1073 (biomarker_via_orthology) | |
| Disease | forced expiratory volume, body mass index | 1.90e-03 | 11 | 177 | 2 | EFO_0004314, EFO_0004340 | |
| Disease | quality of life during menstruation measurement, acne | 1.90e-03 | 11 | 177 | 2 | EFO_0003894, EFO_0009366 | |
| Disease | diabetes mellitus (is_marker_for) | 1.91e-03 | 41 | 177 | 3 | DOID:9351 (is_marker_for) | |
| Disease | oncostatin-M measurement | 2.27e-03 | 12 | 177 | 2 | EFO_0010792 | |
| Disease | tyrosine-protein kinase ZAP-70 measurement | 2.27e-03 | 12 | 177 | 2 | EFO_0020833 | |
| Disease | QRS complex, QRS duration | 2.50e-03 | 45 | 177 | 3 | EFO_0005054, EFO_0005055 | |
| Disease | phospholipids:total lipids ratio | 2.56e-03 | 227 | 177 | 6 | EFO_0020946 | |
| Disease | Squamous cell carcinoma of esophagus | 2.61e-03 | 95 | 177 | 4 | C0279626 | |
| Disease | Short Rib-Polydactyly Syndrome | 2.67e-03 | 13 | 177 | 2 | C0036996 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 2.71e-03 | 96 | 177 | 4 | EFO_0004529, EFO_0008595 | |
| Disease | Alzheimer disease | 2.74e-03 | 485 | 177 | 9 | MONDO_0004975 | |
| Disease | Celiac Disease | 2.83e-03 | 47 | 177 | 3 | C0007570 | |
| Disease | Saldino-Noonan Syndrome | 3.11e-03 | 14 | 177 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 3.11e-03 | 14 | 177 | 2 | C0024507 | |
| Disease | opioid dependence | 3.16e-03 | 237 | 177 | 6 | EFO_0005611 | |
| Disease | lymphocyte count | DAGLB MYCL IL31RA AOC1 KALRN EML6 HECTD4 ARHGEF11 FMNL2 GAB2 GPALPP1 SEPTIN3 CSK C3 RIPOR1 DMRTA1 PHTF1 RAD17 | 3.16e-03 | 1464 | 177 | 18 | EFO_0004587 |
| Disease | cholesteryl esters to total lipids in IDL percentage | 3.38e-03 | 50 | 177 | 3 | EFO_0022247 | |
| Disease | Down syndrome (implicated_via_orthology) | 3.57e-03 | 15 | 177 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 3.57e-03 | 15 | 177 | 2 | EFO_0022328 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 3.61e-03 | 104 | 177 | 4 | EFO_0008591, EFO_0008595 | |
| Disease | high density lipoprotein particle size measurement | 3.69e-03 | 170 | 177 | 5 | EFO_0008592 | |
| Disease | TPE interval measurement | 3.78e-03 | 52 | 177 | 3 | EFO_0004644 | |
| Disease | body weight | DIS3L2 HECTD4 ANO1 ATP13A5 GHSR SEMA6D SLC24A4 MIR17HG SPHKAP TNRC6A ERC2 TLN2 DMRTA1 CTNNA2 DMD PHACTR1 | 3.95e-03 | 1261 | 177 | 16 | EFO_0004338 |
| Disease | pancreatitis | 4.06e-03 | 16 | 177 | 2 | EFO_0000278 | |
| Disease | fourth ventricle volume measurement | 4.06e-03 | 16 | 177 | 2 | EFO_0010303 | |
| Disease | sickle cell anemia (is_implicated_in) | 4.06e-03 | 16 | 177 | 2 | DOID:10923 (is_implicated_in) | |
| Disease | left ventricular diastolic function measurement | 4.21e-03 | 54 | 177 | 3 | EFO_0008204 | |
| Disease | reticulocyte count | CLASP1 MED16 EML6 HECTD4 PROCA1 AKR1A1 GPALPP1 EEF1B2 FAT1 MICAL2 WDR20 TLN2 DMRTA1 FLRT1 | 4.33e-03 | 1045 | 177 | 14 | EFO_0007986 |
| Disease | cholesterol to total lipids in large HDL percentage | 4.43e-03 | 55 | 177 | 3 | EFO_0022234 | |
| Disease | erythrocyte cadmium measurement | 4.59e-03 | 17 | 177 | 2 | EFO_0007807 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 4.59e-03 | 17 | 177 | 2 | EFO_0022232 | |
| Disease | cholesterol to total lipids in large LDL percentage | 4.66e-03 | 56 | 177 | 3 | EFO_0022235 | |
| Disease | large artery stroke | 4.85e-03 | 113 | 177 | 4 | EFO_0005524 | |
| Disease | serum hepcidin measurement | 5.14e-03 | 18 | 177 | 2 | EFO_0004504 | |
| Disease | parahippocampal gyrus volume measurement | 5.14e-03 | 18 | 177 | 2 | EFO_0010318 | |
| Disease | low density lipoprotein particle size measurement | 5.14e-03 | 58 | 177 | 3 | EFO_0008593 | |
| Disease | free cholesterol in medium HDL measurement | 5.14e-03 | 58 | 177 | 3 | EFO_0022267 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 5.33e-03 | 264 | 177 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | myocardial infarction | 5.36e-03 | 350 | 177 | 7 | EFO_0000612 | |
| Disease | cholesterol in medium HDL measurement | 5.39e-03 | 59 | 177 | 3 | EFO_0021903 | |
| Disease | body surface area | DIS3L2 AOC1 DIDO1 GHSR ARHGEF40 MIR17HG TNRC6A MACF1 DLEC1 B4GALNT3 | 5.64e-03 | 643 | 177 | 10 | EFO_0022196 |
| Disease | von Willebrand factor measurement, coronary artery disease | 5.65e-03 | 118 | 177 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | cholesterol to total lipids in IDL percentage | 5.65e-03 | 60 | 177 | 3 | EFO_0022233 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 5.65e-03 | 60 | 177 | 3 | EFO_0022237 | |
| Disease | glomerulonephritis (is_marker_for) | 5.72e-03 | 19 | 177 | 2 | DOID:2921 (is_marker_for) | |
| Disease | peripheral neuropathy, response to docetaxel trihydrate | 5.72e-03 | 19 | 177 | 2 | EFO_0003100, GO_1902519 | |
| Disease | phospholipids in HDL measurement | 5.92e-03 | 61 | 177 | 3 | EFO_0022293 | |
| Disease | migraine disorder | 5.95e-03 | 357 | 177 | 7 | MONDO_0005277 | |
| Disease | coronary artery calcification | 5.99e-03 | 450 | 177 | 8 | EFO_0004723 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PWDSSDRSALLKSKL | 101 | P01160 | |
| KSSEAVPEKTWRAQR | 26 | Q5RGS3 | |
| KILATTPSAVFRVWE | 301 | Q9NRG9 | |
| STLKFPVSKKWEESL | 96 | Q4VNC0 | |
| TLQATSPEIKLKWTS | 1351 | Q8TER5 | |
| KAWKKTSLLSERIPT | 641 | Q96NH3 | |
| KLKLPWTSRDAGAET | 486 | Q00973 | |
| RTTLRKLAVSPKWTN | 151 | Q6L9W6 | |
| ISSTPQEKTKWLRAI | 986 | Q96Q42 | |
| VRESWLLTKLVKTTP | 906 | Q8IZF6 | |
| VSTWESFKRLVTPRK | 756 | Q02952 | |
| SSVDWKSLPDLEILK | 111 | Q9UKT5 | |
| PLTWRISKDKTLDLH | 971 | O15085 | |
| KRAPSTWLTAYVVKV | 1071 | P01024 | |
| LVPSRASSEWDIKKL | 1106 | Q9UKA4 | |
| AIPLRKLKTWYQTSE | 41 | Q92583 | |
| KWTAPEALREKKFST | 351 | P41240 | |
| TPLLKKSAWSSTLTV | 271 | O14490 | |
| VIKETRAEPKKVTSW | 411 | O75879 | |
| RAEPKKVTSWVLNTF | 416 | O75879 | |
| NPWKREVKLLLSSET | 176 | Q9HDC9 | |
| TQPVKRKLEDLSSEW | 2396 | P11532 | |
| SFLWSKKELRLQPSS | 46 | P19801 | |
| WLPSIGKKREIDISS | 266 | Q9NVE4 | |
| KLTFSVIWTLTPEGK | 461 | Q8IYB7 | |
| TSLRIFKWVPVTDSK | 41 | Q9BQE9 | |
| TGKETLAFPLWESTK | 1176 | Q9Y485 | |
| WESTKVVPLSKFVLL | 1186 | Q9Y485 | |
| WLTKTVKETTRTEPI | 181 | Q9NXF7 | |
| ALVAKSSILLDVKPW | 191 | P29692 | |
| RLISKEQTPWDSIKL | 776 | Q7Z2K6 | |
| DSSSKWELLSPKEKI | 291 | A8MX76 | |
| VISSWLSTDPAKDRI | 326 | Q8NFH3 | |
| KTASASKRVLPDTWR | 46 | Q8NFF2 | |
| KRATSWPDLIAKVFR | 146 | P15918 | |
| SLETSTIKKTRFPHW | 166 | O95294 | |
| LRPKVSSTKVTDWVD | 6 | O75943 | |
| IVWKTGPRTTIFVKS | 916 | Q9NVH2 | |
| KPKLWSLAEIATSSD | 331 | P78411 | |
| FWLKVSERPKTSVNL | 306 | P39900 | |
| LSWASPFVSKVKELR | 51 | Q6DT37 | |
| LSRISDEFWLDPSKK | 21 | Q6WBX8 | |
| ASSKTEVHIRPKSWI | 226 | P28838 | |
| ALKVWEEVTPLTFSR | 136 | P09238 | |
| SSTTRLHIEWISKPK | 1336 | Q14517 | |
| EVWSKVTPLKFTKIS | 136 | Q9H306 | |
| PESWAKETFLTQKLR | 1596 | P52948 | |
| SPKWTSKVVTYRIVS | 101 | P09237 | |
| RAWGKSPTDSVLKIL | 801 | Q96PY6 | |
| TVTITWKEIPKSERK | 436 | Q8NI17 | |
| IAWSALVKLFDPVKS | 576 | Q8N6Q8 | |
| DKTPKTWEGRLIAAT | 321 | O43525 | |
| KKREIRSTPSLAWEI | 3051 | Q5SZK8 | |
| DVKISSKRYTWTKLP | 6 | Q75NE6 | |
| KALKVWEEVTPLTFS | 136 | P08254 | |
| WDTVTVLRKKGPTAA | 6 | O60869 | |
| WETKKILAVSFAPLI | 206 | Q9NV79 | |
| RTKTWRPSIVFKRDT | 186 | Q9NZN1 | |
| RKPTKNSEERLTSWS | 406 | Q2TBE0 | |
| EISTKRTSIISLTPW | 261 | P34910 | |
| KSSEAVPEKTWRAQR | 26 | Q4VXF1 | |
| LKDVKWSSVAVPLDL | 11 | Q9H706 | |
| TLKKWLTSPVRRLNS | 1766 | O60229 | |
| RSTTPSEDIWKKFEL | 21 | P12525 | |
| SKPTDISWRDTLSQK | 161 | Q9H8J5 | |
| RTIVKTLLPWDSDES | 1021 | Q9UMN6 | |
| LTDKVKLTWRDRFPA | 501 | Q5XXA6 | |
| SIKTFWSPELKKERV | 181 | O15083 | |
| TVSSRLEWKKLGRSV | 56 | P57087 | |
| ALLVKAWETKVFPTI | 2251 | Q9Y4D8 | |
| KPKLWSLAEIATSDL | 326 | Q9BZI1 | |
| PKDSTSTVWKELLLA | 131 | Q8N5X7 | |
| NTTRKQWLKETPDTL | 401 | P51956 | |
| LPATTEILSWKKAIE | 1896 | Q9UPN3 | |
| KSSEAVPEKTWRAQR | 26 | A6NL05 | |
| DKQPTILKWRILSAT | 331 | Q9Y2X0 | |
| PWTRLTAADKAAIRK | 541 | Q9C0D0 | |
| SKAAPVEWRKGSETL | 3826 | Q5VST9 | |
| FAISTKPTWLERAKE | 1216 | Q9UHC9 | |
| WLPTASQKKLRTRTI | 96 | Q3MJ16 | |
| ERSWAVATLKIALPS | 3621 | Q8NCM8 | |
| KGRKTVTAWDTAIAP | 66 | P10398 | |
| IITTPPLKDFSLWEK | 3141 | P04114 | |
| LKRTPSADVIQKWIT | 471 | Q9C0G6 | |
| VVTVLLPSKRSKDYW | 4131 | Q9C0G6 | |
| SRSASPDSRKVVKWN | 301 | Q9H4Z3 | |
| KWDPKSLEIRTLTVE | 11 | P26232 | |
| FKWDPKSLEIRTLAV | 11 | P35221 | |
| RKLSTLKDESSRAWT | 346 | Q92847 | |
| AKIIIPKFSLSDWDI | 151 | A8MYV0 | |
| KTAATSVWETRIKLL | 186 | Q8NCG7 | |
| VLSPAIKEEKFLSWV | 186 | A2CJ06 | |
| VSSREEATEKPWLKS | 31 | Q8NCL4 | |
| EATEKPWLKSLVSRK | 36 | Q8NCL4 | |
| PRLTDLSVKTKDVWE | 251 | P06241 | |
| LSVKTKDVWEIPRES | 256 | P06241 | |
| SEWVKDLTATKASLP | 306 | Q5VZB9 | |
| KSEPWITKPRALLSS | 536 | Q14534 | |
| EFLWSKLEPIKVDTS | 916 | Q2V2M9 | |
| TVLSSWPERALISLK | 51 | Q5U4N7 | |
| SIWTDTPADRERKAK | 221 | Q8IXQ4 | |
| RLKPEELVSKELSTW | 756 | Q9BTC0 | |
| ELVSKELSTWKERPA | 761 | Q9BTC0 | |
| PRSLEKSAWRAFKES | 36 | Q8J025 | |
| ISKLRESLTPDGSKW | 111 | Q5SZL2 | |
| DTTLPVTLTEWKLFR | 381 | Q68D51 | |
| SVDKSKPWSRSIEDL | 161 | Q96PY5 | |
| AKWTTPSRSAAKVLT | 406 | Q02643 | |
| KSKTDTLDLPEKTSW | 606 | Q6P179 | |
| AVSLRWTKLPPVKSA | 51 | Q9BQ90 | |
| IKLKEEQRITTTSPW | 261 | P04180 | |
| LWDTDFKPITKIDLR | 261 | Q6ZMW3 | |
| SWSPSVAKKRLAIIS | 1946 | A6NE01 | |
| KALTADSIRITWKAT | 416 | Q9NZU1 | |
| LVAKSSILLDVKPWD | 136 | P24534 | |
| VDSLTWNLTPKAKER | 271 | Q9Y238 | |
| TKSLLPKESRLDTFW | 1171 | Q9ULU4 | |
| KKTFSLSPTVWFLRE | 101 | Q99500 | |
| VLTKSIPSAEVEKWT | 3431 | Q9NZJ4 | |
| SSLEEPTVAKWSRLI | 186 | Q08AI6 | |
| TLTIERWTKEKTEPK | 6 | Q8NCQ7 | |
| WISKSVPRPLTTIDK | 521 | O43781 | |
| SRKESDIRPSKLLTW | 511 | O94851 | |
| LSTAFTKVLPFKDWI | 701 | Q6UXH9 | |
| PKNATRESTSTLKAW | 131 | P78415 | |
| KSSEAVPEKTWRAQR | 26 | Q5TZK3 | |
| AKSSWRPEKLELSDL | 706 | Q7Z2Y5 | |
| IDELPFKSPITKSWS | 536 | Q9UQC2 | |
| WPAKVLARTATSTKN | 16 | Q2TAK8 | |
| KKDRSDWLIVFSPDT | 336 | Q9BVN2 | |
| VFSLRWKLPSLTTDE | 21 | P59025 | |
| DSTVRVWSVTPKKLR | 491 | Q15542 | |
| WLEKKTATALLESPL | 381 | Q96TC7 | |
| KDTVVSRSWNELPKI | 436 | Q2M3C7 | |
| ESEVLLARPFWSSKT | 96 | Q9GZN6 | |
| LPWRKEFTTIKTFSG | 91 | Q8IUW3 | |
| KFSWLTVPEKSLDKE | 71 | P0CF51 | |
| PSLLDYTTKWLTKAA | 236 | B4DZS4 | |
| PSLLDYTTKWLTKAA | 141 | Q5H9J9 | |
| NRTITIALKSPDWIK | 961 | O43426 | |
| KDQLWPAKVLSRSET | 11 | Q5H9M0 | |
| KSFLEIWDRSSPEVK | 221 | O75452 | |
| SDLKPRKTTWLQAAS | 96 | Q9HB40 | |
| PKNATRESTSTLKAW | 131 | P78414 | |
| KALWEKPFISSRTTP | 216 | P29622 | |
| ISEWLDQKLTKSDRP | 196 | P13804 | |
| PTIFRSATLKWKESL | 41 | Q9HCL2 | |
| DLTWDKIAVSLPRSE | 91 | Q96HU1 | |
| PRQVKIIAWTSKTSV | 46 | Q9UIB8 | |
| KLTDTSERPSWRTIV | 626 | Q9NY91 | |
| SKSTRNPLLKWTVGE | 206 | Q8TBZ3 | |
| EIWSSTEETVSPKIK | 366 | O94875 | |
| TSKLWGDVTEIKSPI | 1601 | Q9UPX8 | |
| PREELFVTSKLWNTK | 71 | P14550 | |
| LVTTPEKWDVVTRKS | 581 | Q8N3C0 | |
| RIITWTTEPKSSDVR | 1026 | Q7Z460 | |
| ITWTTEPKSSDVRKA | 826 | O75122 | |
| RWLFETKPLDSINKS | 1176 | A4UGR9 | |
| STWEPTKRELELLKH | 146 | Q9UPT9 | |
| LSLTEKSWPKDSSVV | 201 | Q9ULJ3 | |
| ETPVLTSAWEKIDKL | 171 | Q4G0A6 | |
| WDLRKFEKPVLTLTE | 251 | Q9NXC5 | |
| RSTAPSEDIWKKFEL | 21 | P12524 | |
| TKSKLSIPELSYIWE | 311 | Q8NFH8 | |
| FAKAKPEIPWTSLTR | 61 | Q9UMS5 | |
| SVPETWKAFLESVKK | 311 | P23942 | |
| KSSYEPIATTLRWKQ | 1836 | Q9Y5Y9 | |
| VSRKASSWNREEKIP | 86 | Q9UH03 | |
| EVTSTVATEKKLPLW | 756 | Q96PX9 | |
| DSKTDISWLREPKSK | 946 | Q9BX26 | |
| PISKKRATWETILDG | 326 | Q15022 | |
| AKEVTPRTALLTWTE | 3941 | P22105 | |
| KWQRLRELTKSLESP | 146 | A2RTY3 | |
| QSIWIRTKPSDIIRK | 2211 | Q9HCK1 | |
| LVLRTKPKFWENLTS | 1001 | Q5SRE5 | |
| VSISDRYPTNKWIKL | 381 | Q9UBS9 | |
| PRWDLSKFLRVSTKI | 741 | P27708 | |
| LSKSSPRLITTWEKV | 196 | Q96HH6 | |
| LITLPTEASTWVKLR | 6 | Q9UJL9 | |
| STKWLNESRKPESLL | 906 | Q7Z7G8 | |
| LTTVKRWAASPKSFT | 356 | Q9Y4G6 | |
| VSTKWLAESIRTGKL | 11 | Q16762 | |
| WIVPTAKISEDSKVL | 361 | Q7Z7G0 | |
| ITPKVIDTWRPKLTS | 606 | Q8NFY4 | |
| IDTWRPKLTSSRKFV | 611 | Q8NFY4 | |
| TIKLSLEVTWSPFDK | 311 | Q6ZS17 | |
| TWLPFRTTVFSEEKL | 156 | P21754 | |
| FTEKEWPLLDSSQRK | 66 | Q96PQ6 | |
| NSIKEPQSRLRKWTT | 1526 | Q8NDV7 | |
| KEESLWPRVAVFSTL | 131 | Q6P4I2 | |
| SRWRTKPSTVEVLES | 6 | Q9C0E8 |